MedPath

Research of Prognostic Factors Associated With Healing of Venous Leg Ulcers

Not Applicable
Completed
Conditions
Leg Ulcer
Registration Number
NCT01673412
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

This study was undertaken to identify prospectively which clinical venous leg ulcer (VLU) characteristics known as possible prognostic markers, and which sociodemographic and psychologic factors associated with VLU are associated with complete healing at 24 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
104
Inclusion Criteria
  • ambulatory or hospitalized patients
  • patients over 50 years old
  • one or more venous leg ulcer, lasting for 1 month or more
  • wound area more than 1 cm2
  • clinical findings consistent with established venous disease (skin hyperpigmentation, varicose veins, lipodermatosclerosis), confirmed by venous Doppler duplex ultrasonography performed during the preceding 6 months
  • absence of significant arterial insufficiency assessed by clinical findings (intermittent claudication or resting pain, necrotic or distal foot wound) and by an ankle brachial index (ABI) ≥0.8
  • ability to give informed consent
  • ability to be followed for 24 weeks
Exclusion Criteria
  • ongoing systemic diseases known to be associated with pyoderma gangrenosum or necrotizing vasculitis
  • corticosteroid, cytotoxic or immunosuppressant drug use during the preceding 3 months
  • hypertensive leg ulcer
  • foot ulcer
  • ABI < 0.8

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Healing or non-healing of venous leg ulcers at week 24week 24

Healing or non-healing of venous leg ulcers at week 24

Secondary Outcome Measures
NameTimeMethod
affected-leg characteristicsweek 24

comparison between healed and non healed venous leg ulcers at week 24 for patient affected-leg inclusion characteristics (venous insufficiency classified using CEAP classification, ultrasonography assessment of leg with measurement of the Ankle Brachial Index (ABI) and examination of the leg venous system, number of ulcers on target leg, presence/absence of venous abnormalities (varicose veins, ochre dermatitis, white atrophy, acute hypodermitis), of cutaneous signs of lymphatic insufficiency, of oedema and of ankle articulation ankylosis)

clinical characteristicsweek 24

comparison between healed and non healed venous leg ulcers at week 24 for patient clinical characteristics (age, weight, body mass index, concomitant diseases, medical and surgical history, autonomy, mobility)

psychologic assessmentsweek 24

comparison between healed and non healed venous leg ulcers at week 24 for patient psychologic assessments (self-esteem assessed by Coopersmith self-esteem inventory, symptoms of depression researched with Beck Depression Inventory)

cognitive assessmentsweek 24

comparison between healed and non healed venous leg ulcers at week 24 for patient cognitive assessments (intellectual quotient evaluated by Raven's progressives matrices test, signs of intellectual deterioration assessed by Minimal Mental Status test)

social assessmentweek 24

comparison between healed and non healed venous leg ulcers at week 24 for patient social assessments (assessment of social and occupational group, of education level, of income level and of marital status)

venous leg ulcers inclusion characteristicsweek 24

comparison between healed and non healed venous leg ulcers at week 24 for patient venous leg ulcers inclusion characteristics (size, localization, duration, percentage of granulation/fibrinous tissue, aspect of ulcer's margins, pain)

venous insufficiency treatmentweek 24

comparison between healed and non healed venous leg ulcers at week 24 for patient venous insufficiency treatment (compliance to venous contention assessed by an evaluating questionnaire)

biologic characteristicsweek 24

comparison between healed and non healed venous leg ulcers at week 24 for patient biologic characteristics (complete blood count, hemoglobinemia, albuminemia, and only for patients with diabetes mellitus : glycemia and glycated haemoglobin)

Trial Locations

Locations (35)

Centre Hospitalo-Universitaire d'Amiens - Dermatologie

🇫🇷

Amiens, France

Hôpital Saint Vincent de Paul - Médecine interne et Gériatrie I

🇫🇷

Amiens, France

Hôpital Victor Dupouy - Dermatologie

🇫🇷

Argenteuil, France

Hôpital Saint Jacques - Dermatologie 1

🇫🇷

Besançon, France

CHU de Brest - Dermatologie

🇫🇷

Brest, France

CHU Clémenceau - Dermatologie

🇫🇷

Caen, France

Hôpitaux Civils de Colmar - Service de Dermatologie

🇫🇷

Colmar, France

CHU Bocage - Dermatologie

🇫🇷

Dijon, France

CHU Michallon - Dermatologie

🇫🇷

Grenoble, France

Hôpital C. Foix - Service de Gérontologie

🇫🇷

Ivry, France

Scroll for more (25 remaining)
Centre Hospitalo-Universitaire d'Amiens - Dermatologie
🇫🇷Amiens, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.